As a result of CCSG strategic planning and evaluation of services offered, the former Mouse Tumor Models shared resource (MTM) was renamed the Experimental Tumor Model Shared Resource (ETM). ETM has expanded its experimental models to include xenografts, organoid and spheroid models from patient derived samples. The major objective is to provide high quality, cost-effective, custom services tailored to the needs of individual investigators and to provide a consolidated resource of experimental models and technical expertise for all aspects of in vivo experiments to support the research efforts of CCSG investigators. The ETM shared resource served a total of 65 Roswell users, of which 60 (92%) were CCSG members. ETM is a great value for their users as there are no commercial options that offer the full range of services for in vivo studies that are provided by ETM. The consolidated breeding colonies for the production of animals offer a profound savings over buying the transgenic mice through commercial sources. The ETM resource has two primary areas of focus: (i) experimental studies that utilize cancer models which includes maintaining models; biobank of tissues from each model; and providing technical support for treatment, evaluation of response and tissue procurement; and (ii) histological services for murine tissues. ETM service includes the full spectrum starting with study protocol development, providing experimental models, performing in vivo treatments to tissue procurement and histological staining with standardize murine IHC protocols. The histology services offered by ETM are focused on murine tissues. The resource maintains breeding colonies of several widely used models of prostate cancer. The ETM also maintains transgenic-based models of sarcoma, lung, pancreas (in development), and a carcinogen-induced model of bladder cancer. The ETM establishes and maintains a variety of patient-derived xenograft (PDX) models.
The Specific Aims of the ETM are: 1) To provide a consolidated resource for conducting in vivo studies utilizing experimental models of cancer including biospecimens, experimental models and technical support for in vivo studies, and 2) To provide tissue procurement and histological support for research involving experimental models. ETM plans to establish new PDX models from clinical samples; establish lung squamous carcinomas PDXs with deep molecular characterization; establish PDXs, organoids and spheroids from the same patient samples; provide multiple transgenic models, PDX and 3-D culture methods; and establish the KPC transgenic model, biorepository of pancreatic models and tissues, and patient derived models (xenograft, organoids and spheroids).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016056-42
Application #
9704587
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
42
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Mahoney, Martin C; Erwin, Deborah O; Twarozek, Annamaria Masucci et al. (2018) Leveraging technology to promote smoking cessation in urban and rural primary care medical offices. Prev Med 114:102-106
Cheng, Ting-Yuan David; Darke, Amy K; Redman, Mary W et al. (2018) Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424). J Natl Cancer Inst 110:734-742
Zonneville, Justin; Safina, Alfiya; Truskinovsky, Alexander M et al. (2018) TGF-? signaling promotes tumor vasculature by enhancing the pericyte-endothelium association. BMC Cancer 18:670
Rabi, Thangaiyan; Li, Fengzhi (2018) Multiple mechanisms involved in a low concentration of FL118 enhancement of AMR-MeOAc to induce pancreatic cancer cell apoptosis and growth inhibition. Am J Cancer Res 8:2267-2283
Haring, Rodney C; Henry, Whitney Ann; Hudson, Maui et al. (2018) Views on clinical trial recruitment, biospecimen collection, and cancer research: population science from landscapes of the Haudenosaunee (People of the Longhouse). J Cancer Educ 33:44-51
Elahi, Seerat; Egan, Shawn M; Holling, G Aaron et al. (2018) The RNA binding protein Ars2 supports hematopoiesis at multiple levels. Exp Hematol 64:45-58.e9
La Shu, Shin; Yang, Yunchen; Allen, Cheryl L et al. (2018) Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment. Sci Rep 8:12905
Mayor, Paul C; Eng, Kevin H; Singel, Kelly L et al. (2018) Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol 141:1028-1035
Dasgupta, Subhamoy; Rajapakshe, Kimal; Zhu, Bokai et al. (2018) Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature 556:249-254
Ma, Wen Wee; Xie, Hao; Fetterly, Gerald et al. (2018) A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients. Am J Clin Oncol :

Showing the most recent 10 out of 1555 publications